Back to Skandinaviska Enskilda Banken AB (publ) Skandinaviska Enskilda Banken AB (publ)

DRNADRNA
4 quarters

Position history for Skandinaviska Enskilda Banken AB (publ)Skandinaviska Enskilda Banken AB (publ)'s holdings in DICERNA PHARMACEUTICALS INC

As of its Q3 2021 13F, Skandinaviska Enskilda Banken AB (publ) held 6,300 shares of DRNA (Dicerna Pharmaceuticals), worth $127,000.

Final Value

$0

Final Shares

0

Total Value Change

-$711,000

Total Shares Change

-28,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2021-Q3
New
6,300
-
$127,0000.0%—
31
2020-Q3
Exited
0
-100.0%
$00.0%—
0
2020-Q2
New
28,000
-
$711,0000.0%—
34

Other major holders of DRNA: RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used